Area of research
Nephrology · Rheumatology
Research interest
Research interests include Medicine, Podocyte, Breast cancer, Internal medicine, Diabetic nephropathy, and Ischemia.
FTO aggravates podocyte injury and diabetic nephropathy progression via m6A-dependent stabilization of ACC1 mRNA and promoting fatty acid metabolism
Exploring the predictive “psycho-biomarkers” for checkpoint immunotherapy in cancer
Effect of Danlu capsules for the treatment of breast hyperplasia with mastalgia: a multicenter, double-blind, randomized controlled trial protocol
Effect of HER2-Low Expression on the Efficacy of CDK4/6 Inhibitors in Breast Cancer: A Meta-Analysis
A survey of breastfeeding among women with previous surgery for benign breast disease: a descriptive exploratory study
Neratinib enhances the efficacy of CDK4/6 inhibitor plus endocrine therapy in HR+/HER2-low breast cancer cell line ZR-75-1 via hsa-miR-23a-5p
Effect of HER2-low expression on the efficacy of CDK4/6 inhibitors in breast cancer: A meta-analysis.
Phosphoproteome Profiling of uEVs Reveals p-AQP2 and p-GSK3β as Potential Markers for Diabetic Nephropathy
METTL14 aggravates podocyte injury and glomerulopathy progression through N6-methyladenosine-dependent downregulating of Sirt1
Salvianolate ameliorates oxidative stress and podocyte injury through modulation of NOX4 activity in db/db mice
MicroRNA-21 Is Required for Local and Remote Ischemic Preconditioning in Multiple Organ Protection Against Sepsis*
Retinoic acid improves nephrotoxic serum–induced glomerulonephritis through activation of podocyte retinoic acid receptor α
miR-146a is essential for lipopolysaccharide (LPS)-induced cross-tolerance against kidney ischemia/reperfusion injury in mice
Podocyte-specific deletion of signal transducer and activator of transcription 3 attenuates nephrotoxic serum–induced glomerulonephritis